SCHEMBL6501913

SCHEMBL6501913

CCCOc1ccc(S(=O)(=O)N2CCN(CCOC(=O)C(C)C)CC2)cc1-c1nc2c(CCC)cn(CC)c2c(=O)[nH]1

nearest known ligand 0.83

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ PDE5A O76074 20/20 0.83

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sulfuric Acid SCHEMBL6506109 0.99 PDE5A (0.81) PDE5A
Sulfuric Acid SCHEMBL6506114 0.97 PDE5A (0.79) PDE5A
SCHEMBL6510617 0.95 PDE5A (0.75) PDE5A
SCHEMBL6508312 0.94 PDE5A (0.80) PDE5A
SCHEMBL6510228 0.94 PDE5A (0.82) PDE5A
SCHEMBL6505526 0.94 PDE5A (0.84) PDE5A
SCHEMBL6510171 0.94 PDE5A (0.84) PDE5A
SCHEMBL6499870 0.93 PDE5A (0.83) PDE5A
Hydrochloric Acid SCHEMBL6506209 0.93 PDE5A (0.83) PDE5A
Sulfuric Acid SCHEMBL6499386 0.93 PDE5A (0.82) PDE5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050130983-A1 Pyrrolopyrimidinone derivatives, process for preparation thereof, and method of using and composition comprising them IN2GEN CO., LTD. (KR) 2005-06-16 — — US claimed
EP-1362858-A1 Pyrrolopyrimidinone derivates, process of preparation and use SK Chemicals Co., Ltd. (KR) 2003-11-19 — — EP claimed
US-20050130983-A1 Pyrrolopyrimidinone derivatives, process for preparation thereof, and method of using and composition comprising them IN2GEN CO., LTD. (KR) 2005-06-16 — — US disclosed
EP-1362858-A1 Pyrrolopyrimidinone derivates, process of preparation and use SK Chemicals Co., Ltd. (KR) 2003-11-19 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050130983-A1 Pyrrolopyrimidinone derivatives, process for preparation thereof, and method of using and composition comprising them DHPS, SDHA, FDPS PDE5A 582/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback